Year All2026202520242023202220212020201920182017201620152014 Abivax’s phase 2a ulcerative colitis clinical trial data selected for oral plenary presentation at 14th Congress of European Crohn’s and Colitis Organisation December 20, 2018 Read More Abivax receives DSMB recommendation to continue ongoing extension study of its completed phase 2a clinical trial in ulcerative colitis patients December 06, 2018 Read More Abivax KOL event today in Paris on ABX464 therapeutic-candidate in mid-stage clinical testing for ulcerative colitis and HIV November 09, 2018 Read More Abivax First-Half 2018 Financial Results and Operations Update September 28, 2018 Read More Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients September 04, 2018 Read More Abivax Presents ABX464 Mechanism of Action Data at the 22nd International AIDS Conference (AIDS 2018) July 26, 2018 Read More ABIVAX secures up to EUR 20m Debt Financing from Kreos Capital July 25, 2018 Read More Abivax Sponsors Prize for HIV Cure Projects July 24, 2018 Read More Abivax Completes Dosing in Phase 2a Proof-of-Concept Clinical Trial of ABX464 in Ulcerative Colitis (ABX464-101) July 19, 2018 Read More Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection July 03, 2018 Read More
Abivax’s phase 2a ulcerative colitis clinical trial data selected for oral plenary presentation at 14th Congress of European Crohn’s and Colitis Organisation December 20, 2018 Read More
Abivax receives DSMB recommendation to continue ongoing extension study of its completed phase 2a clinical trial in ulcerative colitis patients December 06, 2018 Read More
Abivax KOL event today in Paris on ABX464 therapeutic-candidate in mid-stage clinical testing for ulcerative colitis and HIV November 09, 2018 Read More
Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients September 04, 2018 Read More
Abivax Presents ABX464 Mechanism of Action Data at the 22nd International AIDS Conference (AIDS 2018) July 26, 2018 Read More
Abivax Completes Dosing in Phase 2a Proof-of-Concept Clinical Trial of ABX464 in Ulcerative Colitis (ABX464-101) July 19, 2018 Read More
Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection July 03, 2018 Read More
